Etanercept (Enbrel) Pharmacokinetic ELISA
Etanercept (trade name Enbrel®) is a protein drug used to treat autoimmune diseases by adsorbing tumor necrosis factor (TNF; a soluble inflammatory cytokine) . Etanercept is a fusion protein produced through expression of recombinant DNA by linking the extracellular ligand-binding portion of TNFRSF1B to the Fc component of human immunoglobulin G1 (IgG1) . It reduces the effect of naturally present TNF, functioning as a decoy receptor that binds to TNF. Etanercept is indicated for the treatment of moderate to severe rheumatoid arthritis (RA), psoriatic arthritis, ankylosing spondylitis, and moderately to severely active polyarticular juvenile idiopathic arthritis. Serum concentration of Enbrel® may predict some clinical outcome during maintenance therapy.
Product Specifications
CAS Number
7732-18-5
Gene ID
7124
Reactivity
Human, mouse, rat
Reaction Volume
15 µL
Target Antigen
Etanercept (Enbrel)
Detection Method
Peroxidase / OD450
Assay Type
ELISA
Assay Principle
Quantification of Etanercept in biological matrices
Assay Protocol
Assay Performance Time
2.5 hours
Sample Type
Serum Plasma
Sample Volume
15ul
Detection Range
50ng/ml - 1.56ng/ml
Precision
<10%, <10%
Sensitivity
Etanercept
Limit Of Detection
1.5ng/ml
Components
Shipping Conditions
Blue Ice
Storage Conditions
-20C, 1 year
Shelf Life
12 months
Specificity
Etanercept
Method
Direct sandwich ELISA
Preservative
None
Preparation
Operating Procedure
Results Calculation
Sample Collection
This kit is compatible with EDTA-plasma, heparinplasma and serum samples. Samples can be stored at or below -20°C for up to 1 year.
Sample Preparation
Plate
Strip
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items